- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02115971
Jumping Exercises Approach in Individuals With Chronic Ankle Instability
The Effect of a 12-week Training Jumping Exercises Program in Individuals With Chronic Ankle Instability: Randomized Controlled Trial Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is a need for;
- more homogeneous sub- groups with chronic functional instability of the ankle.
- Studies are needed that older patients (up to 50 years) and also take into account women.
- In addition, studies should be performed in a clinical environment and also at the same time clinically adapted test can be used as a form measurement.
( Hiller et al. , 2011).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
ZH
-
Zurich, ZH, Switzerland, 8008
- Balgrist Univeresty Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ankle injury more than 6 months ago
- Chronic instability
- Functional instability of the ankle
- Experience with proprioceptive exercises
Exclusion Criteria:
- Foot surgery
- Fresh ankle injury
- Acute foot pain with signs of inflammation
- Mechanical / anatomical ankle instability
- Athletes with regularly jumping exercise (eg volleyball, basketball)
- Taking medications which affect balance and coordination
- Diseases that affect the balance
- Serious diseases such as tumors, infections, neuropathies, severe articular degeneration
- Non-German-speaking patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Jumping exercise
Physical therapy with a focus on specific jumping exercise. The jumping exercise will be performed for 12 weeks (3x/week), with a break of day between workouts. The 40-minute workout is completed 2 times under supervision in the clinic's internal training group for outpatients. 1 time they train on their own at home, based on a defined training program. The training process is documented by the training protocol. The incipient exercise intensity is taking personal performance into account. The exercise intensity is increased by a progressive scheme. |
Total 120min exercise
|
Active Comparator: Strength exercise
Physical Therapy with a focus on stability and strength exercise. Strength exercise arm has also same duration of 12 weeks with comparable intensity. The program is according to a predetermined program. The 60-minute training is completed twice under supervision in the clinic's internal training group for outpatients.There is no contact with participants of other group. Between the two exercise sessions there is a training free day. The training process is documented by the training protocol. The incipient exercise intensity is considering personal performance. The intensity is increased after workout usual principles. The exercises are described with clear image and load parameters. The training exercises are regularly monitored. |
Total 120 min exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in Gait variables
Time Frame: Change from Baseline in Gait variables at week 3, week 7, and at the end of therapy (week 12)
|
Gait variables will be assessed with the OptoGait system OptoGait system is a floor-based photocell system for measuring spatiotemporal gait parameters. All measurements will be executed within 1hour |
Change from Baseline in Gait variables at week 3, week 7, and at the end of therapy (week 12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Balance
Time Frame: Baseline, week 3, week 7, and at the end of therapy (week 12)
|
Time to Stability (Forceplate Accusway AMTI)
|
Baseline, week 3, week 7, and at the end of therapy (week 12)
|
Health questionnaire
Time Frame: Baseline, week 3, week 7, and at the end of therapy (week 12), followup 12 months
|
EQ-5D is a standardised instrument for use as a measure of health outcome.
|
Baseline, week 3, week 7, and at the end of therapy (week 12), followup 12 months
|
Foot function questionnaire
Time Frame: Baseline, week 3, week 7, and at the end of therapy (week 12)
|
The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments.
|
Baseline, week 3, week 7, and at the end of therapy (week 12)
|
Personal calendar
Time Frame: 12 months
|
Participant could enter any new ankle sprain into this calendar.
As soon as possible after new ankle sprain the participant had to fill in the date, its cause, and sprain-related injuries.
The calendar pages contained questions about the circumstances surrounding the new ankle sprain, including how and where it happened, activity performed, possible injury symptoms, time to recover and whether medical assistance or physical therapy was needed.
Participants are also requested to record direct medical costs (e.g.
physiotherapy, visits to general practitioners and medical specialists, nursing care, and medication) and indirect cost (e.g.
disability related loss) using the "personal calendar".
At the end of 2 month, a calendar page was sent by each patient to the investigators
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jaap Swanneburg, PhD, Balgrist Univeresty Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Balgrist 2009-124
- KEK-ZH-Nr. 2009-124 (Other Identifier: Ethics commission of the Canton Zurich, Switzerland)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsActive, not recruitingChronic Conditions, Multiple | Chronic ConditionDenmark
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of Alabama at BirminghamRecruitingDisability Physical | Chronic Conditions, Multiple | Chronic ConditionUnited States
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Radboud University Medical CenterRecruiting
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
Clinical Trials on Jumping exercise
-
Staffordshire UniversityTerminatedOsteoporosis, PostmenopausalUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of GlasgowUnknown
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioActive, not recruiting
-
Mattias LorentzonCompletedOsteoporosis | Postmenopause
-
Riphah International UniversityCompletedDevelopmental Coordination DisorderPakistan
-
Visnja KaticUniversity of Rijeka; Clinical Hospital Center RijekaCompletedMalocclusion, Angle Class IICroatia
-
Universidad de ZaragozaUnknown
-
Loughborough UniversityCompletedBone Resorption | Energy Supply; Deficiency | Female Athlete Triad | Relative Energy Deficiency in Sport | Bone AtrophyUnited Kingdom
-
University of WarsawMedical University of Warsaw; Institute of Psychiatry and Neurology, WarsawCompletedPsychotic Disorders | Schizophrenia
-
Cairo UniversityNot yet recruitingImmediate Implant | Autogenous Tooth Graft | Estetic Zone | Autogenous Bone Graft | Jumping Gap | Crestal Bone LevelEgypt